Imugene Ltd News

Imugene Ltd: Updated Appendix 3Z

Nov 20 15:25

Imugene Ltd: Final Director's Interest Notice

Nov 20 14:13

Imugene Ltd: Director Resignation

Nov 15 05:23

Imugene Ltd: Imugene 2024 AGM Results

Nov 14 10:59

Imugene Ltd: Imugene AGM Presentation

Nov 14 05:24

Imugene Ltd: onCARlytics Trial Doses First Patient in IT Combination Arm

Nov 11 06:03

Imugene Ltd: Imugene Opens First Australian Site for azer-cel Trial

Nov 8 07:08

Imugene Ltd: Complete Response in MAST Study Maintained Over Two Years

Nov 5 06:04

Imugene Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Oct 31 06:10

Imugene Ltd: Notification regarding unquoted securities - IMU

Oct 14 13:40

Imugene Ltd: Notification of cessation of securities - IMU

Oct 14 13:37

Imugene Ltd: Application for quotation of securities - IMU

Oct 14 13:36

Imugene Ltd: Notice of Annual General Meeting/Proxy Form

Oct 14 13:28

Imugene Ltd: Change of Director's Interest Notice - PH

Sep 30 15:01

Imugene Ltd: Imugene Receives Orphan Drug Designation for VAXINIA

Sep 18 11:06

Imugene Ltd: Appendix 2A

Sep 11 14:59

Imugene Ltd: Imugene Corporate Presentation

Sep 9 08:12

Imugene Ltd: Cleansing Notice

Sep 4 14:32

Imugene Ltd: Application for quotation of securities - IMU

Sep 4 14:29

Imugene Ltd: Imugene Azer-cel Webinar Presentation

Sep 4 08:19